PPARGC1A and atrial fibrillation: Using left atria derived from AF patients, a rabbit model of AF, and HL1 cells, it was demonstrated that fenofibrate inhibited atrial metabolic remodeling in AF through the peroxisome proliferator-activated receptor alpha (PPAR-α)/SIRT1/PGC-1α pathway [109].